Clinical Trials on Usher Syndrome, Type 1

Total 6957 results

University Hospital, Toulouse
Institut National de la Santé Et de la Recherche Médicale, France; Centre National...

Withdrawn

The Role of the Thymus in Type I Diabetes. (TregDiab)

Type1 Diabetes

France
Universitaire Ziekenhuizen KU Leuven
KU Leuven

Completed

Proof of Concept - Identification of Patient-specific Parameters for Bolus Calculators for Type 1 Diabetes (POC-IDENTITY-1)

Type1 Diabetes Mellitus

Belgium
Annesofie Lunde Jensen

Completed

DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes

Type1 Diabetes Mellitus

Denmark
Zhejiang Provincial People's Hospital

Not yet recruiting

Efficacy and Safety of Recombinant Human Insulin Patch ZJSRM2021

Type2 Diabetes | type1diabetes

China
Medtronic Diabetes

Completed

Performance Evaluation of an Advanced Algorithm With CGM in Adults, Adolescents, and Pediatrics

Type 1 Diabetes Mellitus | Type2 Diabetes Mellitus

United States
SpringWorks Therapeutics, Inc.

Active, not recruiting

MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (ReNeu)

Plexiform Neurofibroma | Neurofibromatosis Type 1 (NF1)

United States
University Hospital, Caen
Jozef Stefan Institute; INSERM UMR-S 1075 COMETE, Caen, France; CNRS UMR 5220...

Recruiting

Impact of Gravity on Cardiac Hemodynamics (ACUITY)

Healthy | Diabetes type1

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Residual Insulin Secretion in Patients With Type 1 Diabetes Under a Low Carbohydrate Diet or a Ketogenic Diet (KetoDiab)

Type1 Diabetes

France
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; University of Minnesota

Active, not recruiting

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study (CLVerEx)

Type1 Diabetes

United States
Jaeb Center for Health Research
Juvenile Diabetes Research Foundation; University of Minnesota; Medtronic; DexCom... and other collaborators

Completed

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer)

Type1 Diabetes

United States
University of Valencia

Active, not recruiting

Protocol for Self-Compassion Intervention for Teens With Diabetes Type 1 and Their Caregivers (SWEET)

Diabetes type1

Spain
Immunomolecular Therapeutics, Inc.
WCCT Global

Completed

Multiple Ascending Dose (MAD) Study of IMT-002 in HLA-DQ8-positive Type 1 Diabetes

Type1 Diabetes

United States
University Hospital, Lille

Unknown

Assessment of Individual Follow-up by Coaching Program for Type 1 Diabetes Children (DIAB-HELP)

Diabetes type1

France
National Institute of Diabetes and Digestive and...

Withdrawn

Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes (TN-23)

Type1 Diabetes Mellitus
Insulet Corporation

Completed

Insulet Artificial Pancreas Free-Living IDE3

Type1 Diabetes Mellitus

United States
University of Saskatchewan
The Hospital for Sick Children; University of Calgary; Children's Hospital of...

Recruiting

Canadian Bone Strength Development Study (CanBSDS)

Type-1 Diabetes

Canada
Centre Hospitalier Universitaire Dijon

Completed

Search for a Link Between the Different Variables for Glycaemia and Oxidative Stress or Impaired HDL Function (Holter Gly)

Type-1 Diabetes

France
Eddii, Inc.

Completed

Safety and Feasibility Study of the Eddii Mobile Application

Type-1 Diabetes

United States
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)

Plexiform Neurofibroma Associated With Neurofibromatosis Type 1

Israel
University of California, San Diego
Juvenile Diabetes Research Foundation

Completed

Dapagliflozin Effects on Hypoglycemia

Type1 Diabetes Mellitus

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

The International Diabetes Closed Loop (iDCL) Trial: Protocol 1 (iDCL)

Type1 Diabetes Mellitus

United States
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Terminated

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients (T1DM AP)

Type1 Diabetes Mellitus

United States
Radboud University Medical Center
HypoResolve

Unknown

Current State of Impaired Awareness of Hypoglycaemia in People With Type 1 Diabetes

Diabetes type1

Netherlands
Massachusetts General Hospital

Completed

The Insulin-Only Bionic Pancreas Bridging Study- Pediatric Transitional Study

Type1 Diabetes Mellitus

United States
Universidad Loyola Andalucia

Unknown

Evaluation of the Effectiveness of a Program of Emotional Intelligence in Adolescents With Type 1 Diabetes (INTEDI) (INTEDI)

Type1 Diabetes Mellitus

Spain
Jessa Hospital

Completed

Comparison Between Enlite and Flash Glucose Monitoring

Type1 Diabetes Mellitus

Belgium
Eli Lilly and Company

Completed

A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)

Type1 Diabetes Mellitus

United States
Adocia

Completed

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Type1 Diabetes Mellitus

Germany
Chinese University of Hong Kong

Recruiting

Chinese Smartphone App for 6-18 Years With T1DM - RCT

Type1 Diabetes Mellitus

Hong Kong
Göteborg University
Gothia Forum - Center for Clinical Trial; Statistiska Konsultgruppen

Recruiting

Ixekizumab Diabetes Intervention Trial (I-DIT) (I-DIT)

Type1 Diabetes Mellitus

Sweden
University of Exeter
King's College London; Benaroya Research Institute; Royal Devon and Exeter NHS...

Recruiting

EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study) (EXE-T1D)

Type1 Diabetes Mellitus

Netherlands, United States, United Kingdom
REMD Biotherapeutics, Inc.

Completed

Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

United States
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); DexCom... and other collaborators

Completed

A Pilot Test of t:Slim X2 With Control-IQ Technology

Type1 Diabetes Mellitus

United States
Sanofi

Completed

A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus

Germany
Breath of Life International Pharma Ltd

Withdrawn

BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus

Type1 Diabetes Mellitus
Eli Lilly and Company

Completed

A Study of LY900014 in a Medtronic Pump

Type1 Diabetes Mellitus

United States
Imperial College London
Oxford Brookes University; Institut d'Investigació Biomèdica de Girona Dr.... and other collaborators

Completed

Patient Empowerment Through Predictive Personalised Decision Support (PEPPER)

Type1 Diabetes Mellitus

United Kingdom
Wockhardt

Completed

Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM

Type1 Diabetes

United States
University of California, Irvine
Juvenile Diabetes Research Foundation

Completed

PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus

Type1 Diabetes Mellitus

United States
AstraZeneca

Completed

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Type 2 Diabetes Mellitus | Type 1 Diabetes Mellitus

United States
Hospices Civils de Lyon

Unknown

Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping (SB-CARTO)

Brugada Syndrome Type 1

France
Hoffmann-La Roche

Completed

European, Open-label, Prospective, Multinational, Multicenter Study in Adult Subjects With Type 1 or Type 2 Diabetes Previously on MDI or CSII Therapy. Subjects Home Setting is Considered Routine Practice.

Type 2 Diabetes, Type 1 Diabetes

Austria, United Kingdom
National Institute of Diabetes and Digestive and...

Completed

Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes (TN14)

Type 1 Diabetes | Preservation of Insulin Secretion | Newly Diagnosed Type 1 Diabetes | Canakinumab in Type 1 Diabetes

United States, Canada
University of California, Irvine
Doris Duke Charitable Foundation

Withdrawn

The Genetics of Diabetes in Southern California Chinese Americans

Metabolic Syndrome | Type 1 Diabetes | Type 2 Diabetes

United States
MacroGenics
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaborators

Active, not recruiting

A Study of MGD020 Alone or Combined With MGD014 in Persons With HIV-1 on Antiretroviral Therapy

Human Immunodeficiency Virus I Infection | Immunodeficiency Virus Type 1, Human | Human Immunodeficiency Virus Type 1

United States
St. Olavs Hospital

Recruiting

Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1

Type 1 Diabetes

Norway
Chang Gung University
Chang Gung Memorial Hospital

Recruiting

Effectiveness of The Health Care CEO App for T1D

Type 1 Diabetes Mellitus

Taiwan
Poznan University of Medical Sciences

Recruiting

Insulin Therapy and Lipoproteins' Profile in Type 1 Diabetes. (InLipoDiab1)

Type 1 Diabetes Mellitus

Poland
Rabin Medical Center
DreaMed Diabetes

Terminated

Use of Insulin Adjustment Device DreaMed Endo Digital During Routine Clinical Use for Subjects With Diabetes Type 1 (Endo digital)

Type 1 Diabetes

Israel
Insulet Corporation

Completed

Omnipod Horizon™ Automated Glucose Control System Preschool Cohort

Type 1 Diabetes Mellitus

United States

Clinical Trials on Usher Syndrome, Type 1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations